Excision repair cross‐complementing gene‐1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter‐1 expression and prognostic value in biliary tract malignancy (Englisch)
- Neue Suche nach: Fisher, Sarah B.
- Neue Suche nach: Fisher, Kevin E.
- Neue Suche nach: Patel, Sameer H.
- Neue Suche nach: Lim, Matthew G.
- Neue Suche nach: Kooby, David A.
- Neue Suche nach: El‐Rayes, Bassel F.
- Neue Suche nach: Staley, Charles A. III
- Neue Suche nach: Adsay, N. Volkan
- Neue Suche nach: Farris, Alton B. III
- Neue Suche nach: Maithel, Shishir K.
- Neue Suche nach: Fisher, Sarah B.
- Neue Suche nach: Fisher, Kevin E.
- Neue Suche nach: Patel, Sameer H.
- Neue Suche nach: Lim, Matthew G.
- Neue Suche nach: Kooby, David A.
- Neue Suche nach: El‐Rayes, Bassel F.
- Neue Suche nach: Staley, Charles A. III
- Neue Suche nach: Adsay, N. Volkan
- Neue Suche nach: Farris, Alton B. III
- Neue Suche nach: Maithel, Shishir K.
In:
Cancer
;
119
, 2
;
454-462
;
2013
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Excision repair cross‐complementing gene‐1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter‐1 expression and prognostic value in biliary tract malignancy
-
Beteiligte:Fisher, Sarah B. ( Autor:in ) / Fisher, Kevin E. ( Autor:in ) / Patel, Sameer H. ( Autor:in ) / Lim, Matthew G. ( Autor:in ) / Kooby, David A. ( Autor:in ) / El‐Rayes, Bassel F. ( Autor:in ) / Staley, Charles A. III ( Autor:in ) / Adsay, N. Volkan ( Autor:in ) / Farris, Alton B. III ( Autor:in ) / Maithel, Shishir K. ( Autor:in )
-
Erschienen in:Cancer ; 119, 2 ; 454-462
-
Verlag:
- Neue Suche nach: Wiley Subscription Services, Inc., A Wiley Company
-
Erscheinungsdatum:15.01.2013
-
Format / Umfang:9 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 119, Ausgabe 2
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 247
-
New prostate cancer drugs hold promisePrintz, Carrie et al. | 2013
- 248
-
Smokers have 10 times more genetic damage in lung cancer tumorsPrintz, Carrie et al. | 2013
- 249
-
New report: Cancer leading cause of death in US HispanicsPrintz, Carrie et al. | 2013
- 250
-
Effect of Massachusetts health insurance reform on mammography use and breast cancer stage at diagnosisKeating, Nancy L. / Kouri, Elena M. / He, Yulei / West, Dee W. / Winer, Eric P. et al. | 2013
- 259
-
The role of clinicians in determining radioactive iodine use for low‐risk thyroid cancerHaymart, Megan R. / Banerjee, Mousumi / Yang, Di / Stewart, Andrew K. / Koenig, Ronald J. / Griggs, Jennifer J. et al. | 2013
- 266
-
Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastasesMiranda, Elena / Bianchi, Paolo / Destro, Annarita / Morenghi, Emanuela / Malesci, Alberto / Santoro, Armando / Laghi, Luigi / Roncalli, Massimo et al. | 2013
- 277
-
Induction gemcitabine and oxaliplatin therapy followed by a twice‐weekly infusion of gemcitabine and concurrent external‐beam radiation for neoadjuvant treatment of locally advanced pancreatic cancerLeone, Francesco / Gatti, Marco / Massucco, Paolo / Colombi, Federica / Sperti, Elisa / Campanella, Delia / Regge, Daniele / Gabriele, Pietro / Capussotti, Lorenzo / Aglietta, Massimo et al. | 2013
- 285
-
Carbohydrate antigen 19‐9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine‐containing chemotherapyBauer, Todd M. / El‐Rayes, Bassel F. / Li, Xiaobai / Hammad, Nazik / Philip, Philip A. / Shields, Anthony F. / Zalupski, Mark M. / Bekaii‐Saab, Tanios et al. | 2013
- 293
-
Gene expression‐based chemical genomics identifies heat‐shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinomaChen, Ming‐Huang / Lin, Kun‐Ju / Yang, Wu‐Lung R. / Kao, Ya‐Wen / Chen, Tsung‐Wen / Chao, Shu‐Chaou / Chang, Peter Mu‐Hsin / Liu, Chun‐Yu / Tzeng, Cheng‐Hwai / Chao, Yee et al. | 2013
- 304
-
Genome‐wide identification of Epstein‐Barr virus–driven promoter methylation profiles of human genes in gastric cancer cellsZhao, Junhong / Liang, Qiaoyi / Cheung, Kin‐Fai / Kang, Wei / Lung, Raymond W. M. / Tong, Joanna H. M. / To, Ka Fai / Sung, Joseph J. Y. / Yu, Jun et al. | 2013
- 313
-
Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinomaCao, Yun / Zhang, Zhi‐Ling / Zhou, Ming / Elson, Paul / Rini, Brian / Aydin, Hakan / Feenstra, Kristin / Tan, Min‐Han / Berghuis, Bree / Tabbey, Rebeka et al. | 2013
- 325
-
The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapySong, Suisui / Rudra, Sonali / Hasselle, Michael D. / Dorn, Paige L. / Mell, Loren K. / Mundt, Arno J. / Yamada, S. Diane / Lee, Nita K. / Hasan, Yasmin et al. | 2013
- 332
-
BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinomaPennington, Kathryn P. / Walsh, Tom / Lee, Ming / Pennil, Christopher / Novetsky, Akiva P. / Agnew, Kathy J. / Thornton, Anne / Garcia, Rochelle / Mutch, David / King, Mary‐Claire et al. | 2013
- 339
-
Results from AMBER, a randomized phase 2 study of bevacizumab and bortezomib versus bortezomib in relapsed or refractory multiple myelomaWhite, Darrell / Kassim, Adetola / Bhaskar, Birbal / Yi, Jing / Wamstad, Karen / Paton, Virginia E. et al. | 2013
- 348
-
First‐line combination of gemcitabine, oxaliplatin, and L‐asparaginase (GELOX) followed by involved‐field radiation therapy for patients with stage IE/IIE extranodal natural killer/T‐cell lymphomaWang, Liang / Wang, Zhi‐hui / Chen, Xiao‐qin / Li, Ya‐jun / Wang, Ke‐feng / Xia, Yun‐fei / Xia, Zhong‐jun et al. | 2013
- 356
-
Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomasJohnson, Melissa L. / Sima, Camelia S. / Chaft, Jamie / Paik, Paul K. / Pao, William / Kris, Mark G. / Ladanyi, Marc / Riely, Gregory J. et al. | 2013
- 363
-
Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemiaShanafelt, Tait D. / Call, Timothy G. / Zent, Clive S. / Leis, Jose F. / LaPlant, Betsy / Bowen, Deborah A. / Roos, Michelle / Laumann, Kristina / Ghosh, Asish K. / Lesnick, Connie et al. | 2013
- 371
-
Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T‐cell non‐Hodgkin lymphomaMahadevan, Daruka / Unger, Joseph M. / Spier, Catherine M. / Persky, Daniel O. / Young, Fay / LeBlanc, Michael / Fisher, Richard I. / Miller, Thomas P. et al. | 2013
- 380
-
Phase 2 trial of linifanib (ABT‐869) in patients with unresectable or metastatic hepatocellular carcinomaToh, Han Chong / Chen, Pei‐Jer / Carr, Brian I. / Knox, Jennifer J. / Gill, Sharlene / Ansell, Peter / McKeegan, Evelyn M. / Dowell, Barry / Pedersen, Michelle / Qin, Qin et al. | 2013
- 388
-
Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristicsChow, Wong‐Ho / Shuch, Brian / Linehan, W. Marston / Devesa, Susan S. et al. | 2013
- 395
-
Adjuvant chemotherapy for stage III colon cancer in the oldest oldAbraham, Anasooya / Habermann, Elizabeth B. / Rothenberger, David A. / Kwaan, Mary / Weinberg, Armin D. / Parsons, Helen M. / Gupta, Pankaj / Al‐Refaie, Waddah B. et al. | 2013
- 404
-
Type 2 diabetes mellitus and survival in pancreatic adenocarcinomaHwang, Allen / Narayan, Vivek / Yang, Yu‐Xiao et al. | 2013
- 411
-
Recommendations for including multiple symptoms as endpoints in cancer clinical trialsCleeland, Charles S. / Sloan, Jeff A. / Cella, David / Chen, Connie / Dueck, Amylou C. / Janjan, Nora A. / Liepa, Astra M. / Mallick, Rajiv / O'Mara, Ann / Pearson, Jay D. et al. | 2013
- 421
-
Who makes the decision regarding the treatment of clinically localized prostate cancer–the patient or physician?Song, Lixin / Chen, Ronald C. / Bensen, Jeannette T. / Knafl, George J. / Nielsen, Matthew E. / Farnan, Laura / Wallen, Eric M. / Mishel, Merle / Pruthi, Raj S. / Mohler, James L. et al. | 2013
- 429
-
General population norms for the Functional Assessment of Cancer Therapy–Kidney Symptom Index (FKSI)Butt, Zeeshan / Peipert, John / Webster, Kimberly / Chen, Connie / Cella, David et al. | 2013
- 438
-
Clinical pattern and associations of oxaliplatin acute neurotoxicityArgyriou, Andreas A. / Cavaletti, Guido / Briani, Chiara / Velasco, Roser / Bruna, Jordi / Campagnolo, Marta / Alberti, Paola / Bergamo, Francesca / Cortinovis, Diego / Cazzaniga, Marina et al. | 2013
- 445
-
An analysis of human equilibrative nucleoside transporter‐1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross‐complementing gene‐1 expression in patients with resected pancreas adenocarcinomaFisher, Sarah B. / Patel, Sameer H. / Bagci, Pelin / Kooby, David A. / El‐Rayes, Bassel F. / Staley, Charles A. III / Adsay, N. Volkan / Maithel, Shishir K. et al. | 2013
- 454
-
Excision repair cross‐complementing gene‐1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter‐1 expression and prognostic value in biliary tract malignancyFisher, Sarah B. / Fisher, Kevin E. / Patel, Sameer H. / Lim, Matthew G. / Kooby, David A. / El‐Rayes, Bassel F. / Staley, Charles A. III / Adsay, N. Volkan / Farris, Alton B. III / Maithel, Shishir K. et al. | 2013
- 463
-
Dental x‐rays and risk of meningiomaJorgensen, Timothy J. et al. | 2013
- 464
-
Shortcomings of study on dental x‐rays and risk of meningiomaCalnon, William R. et al. | 2013
- 465
-
Dental x‐rays and risk of meningioma: Response to Drs. Calnon, Jorgensen, and WhiteClaus, Elizabeth B. / Wiemels, Joseph / Wrensch, Margaret et al. | 2013
- 467
-
Erratum| 2013